Trial
NCT05060549
Dopamine D3 Receptor Occupancy in Bipolar Depression
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Bipolar Depression
Intervention
Cariprazine
Why stopped
Funding decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-14